BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. J Nucl Med 2020;61:743-50. [PMID: 31757844 DOI: 10.2967/jnumed.119.232934] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Costa IM, Cheng J, Osytek KM, Imberti C, Terry SYA. Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides. Nucl Med Biol 2021;98-99:18-29. [PMID: 33964707 DOI: 10.1016/j.nucmedbio.2021.03.010] [Reference Citation Analysis]
2 Wu M, Shi K, Huang R, Liu C, Yin L, Yong W, Sun J, Wang G, Zhong Z, Gao M. Facile preparation of 177Lu-microspheres for hepatocellular carcinoma radioisotope therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.007] [Reference Citation Analysis]
3 Derlin T, Bogdanova N, Ohlendorf F, Ramachandran D, Werner RA, Ross TL, Christiansen H, Bengel FM, Henkenberens C. Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel) 2021;13:1516. [PMID: 33806081 DOI: 10.3390/cancers13071516] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lundsten S, Berglund H, Jha P, Krona C, Hariri M, Nelander S, Lane DP, Nestor M. p53-Mediated Radiosensitization of 177Lu-DOTATATE in Neuroblastoma Tumor Spheroids. Biomolecules 2021;11:1695. [PMID: 34827693 DOI: 10.3390/biom11111695] [Reference Citation Analysis]
5 Schwarzenböck SM, Garibotto V. Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine—a global competition for excellence. Eur J Nucl Med Mol Imaging 2020;47:1808-19. [DOI: 10.1007/s00259-020-04833-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Lobachevsky P, Forrester HB, Ivashkevich A, Mason J, Stevenson AW, Hall CJ, Sprung CN, Djonov VG, Martin OA. Synchrotron X-Ray Radiation-Induced Bystander Effect: An Impact of the Scattered Radiation, Distance From the Irradiated Site and p53 Cell Status. Front Oncol 2021;11:685598. [PMID: 34094987 DOI: 10.3389/fonc.2021.685598] [Reference Citation Analysis]
7 Ritt P, Jobic C, Beck M, Schmidkonz C, Kuwert T, Uder M, Brand M. Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy. J Nucl Med 2021;62:379-85. [PMID: 32737244 DOI: 10.2967/jnumed.120.243782] [Reference Citation Analysis]
8 O'neill E, Cornelissen B. Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.02.004] [Reference Citation Analysis]
9 Shi X, Li Q, Zhang C, Pei H, Wang G, Zhou H, Fan L, Yang K, Jiang B, Wang F, Zhu R. Semiconducting polymer nano-radiopharmaceutical for combined radio-photothermal therapy of pancreatic tumor. J Nanobiotechnology 2021;19:337. [PMID: 34689758 DOI: 10.1186/s12951-021-01083-0] [Reference Citation Analysis]
10 Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S, Welzel M, Fischer C, Grötzinger C, Brenner W, Baum RP, Grabowski P. Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo. Neoplasia 2021;23:80-98. [PMID: 33246310 DOI: 10.1016/j.neo.2020.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Delbart W, Ghanem GE, Karfis I, Flamen P, Wimana Z. Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines. Nucl Med Biol 2021;96-97:68-79. [PMID: 33839677 DOI: 10.1016/j.nucmedbio.2021.03.006] [Reference Citation Analysis]
12 Reuvers TGA, Kanaar R, Nonnekens J. DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage. Cancers (Basel) 2020;12:E2098. [PMID: 32731592 DOI: 10.3390/cancers12082098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]